Glucose News and Research

RSS

Drinking soft drinks to rehydrate worsens dehydration-related kidney injury

Repeated heat-related dehydration has been associated with increased risk of chronic kidney damage in mice. A new study in rats published in the American Journal of Physiology—Regulatory, Integrative and Comparative Physiology reports that drinking soft drinks to rehydrate worsened dehydration and kidney injury.

7 Jun 2016

Study finds no added benefit of empagliflozin alone or in combination for type 2 diabetes

Empagliflozin has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet and exercise alone do not provide adequate glycaemic control.

6 Jun 2016

Metformin along with chemotherapy/radiation improves outcomes in head and neck cancer patients

Researchers at the University of Cincinnati College of Medicine have found that adding increasing doses of an approved Type 2 diabetes drug, metformin, to a chemotherapy and radiation treatment regimen in head and neck cancer patients is not well tolerated if escalated too quickly, but allowing slower escalation could be beneficial.

6 Jun 2016

New understanding of established link between glucose and improved self-control

In the age of the 'sugar tax', good news about glucose is hard to come by. But an Australian scientist has just proposed a new understanding of the established link between the sweet stuff and improved self-control.

4 Jun 2016

Severe obesity may contribute to infection risk after bypass surgery

Severely obese patients who undergo a coronary artery bypass are more likely to develop an infection after surgery and stay in hospital longer, compared with people of normal weight, according to a study published in the Journal of the American Heart Association.

2 Jun 2016

New technique could help reduce chances of drug failure during later stages of clinical trials

An approach that could reduce the chances of drugs failing during the later stages of clinical trials has been demonstrated by a collaboration between the University of Cambridge and pharmaceutical company GlaxoSmithKline.

2 Jun 2016

New NPS MedicineWise program aims to help health professionals improve diabetes management

A new educational program aims to help health professionals keep up to date with the latest evidence on second and third line medicines for lowering blood glucose.

2 Jun 2016

University of Arizona selects Cubresa’s NuPET scanner for cancer research

Cubresa Inc., a medical imaging company that develops and markets molecular imaging systems, today announced that their compact PET scanner called NuPET™ for simultaneous preclinical PET (Positron Emission Tomography) and MRI (Magnetic Resonance Imaging) has been selected by the University of Arizona (UA).

From Cubresa Inc. 1 Jun 2016

Innovative model identifies T2D trajectory and related risks

An innovative model for determining a person's risk of developing type 2 diabetes (T2D) overcomes many of the challenges associated with estimating the onset of a chronic condition based on the usual sequence of comorbid conditions that lead up to a diagnosis of T2D.

1 Jun 2016

Majority youths with autism or intellectual disability receive antipsychotics, study finds

About one in ten youths treated with an antipsychotic are diagnosed with autism spectrum disorder or intellectual disability. Conversely, one in six youths diagnosed with autism spectrum disorder has been prescribed antipsychotics.

31 May 2016

Global study finds weight loss could be key for tackling pre-diabetes

Type 2 Diabetes is the world’s fastest growing chronic disease and is linked to the increasing number of overweight people. One in 16 people (3.9 million) in the UK are thought to have diabetes, both diagnosed and undiagnosed.

31 May 2016

NASA releases new video that highlights Mark and Scott Kelly's metabolites

NASA's Human Research Program is releasing "Metabolomics: You Are What You Eat" video to highlight its Twins Study which uses omics to study Mark and Scott Kelly's metabolites.

28 May 2016

Salk scientists discover REV-ERBα protein that controls strength of circadian rhythm

At noon every day, levels of genes and proteins throughout your body are drastically different than they are at midnight. Disruptions to this 24-hour cycle of physiological activity are why jet lag or a bad night's sleep can alter your appetite and sleep patterns for days--and even contribute to conditions like heart disease, sleep disorders and cancers.

27 May 2016

New hydrogel-based biochip may help in early diagnosis of bowel cancer

Researchers from the Moscow Institute of Physics and Technology, the Engelhardt Institute of Molecular Biology, the Institute of Bioorganic Chemistry and a number of other Russian research centers have developed a new method of diagnosing colorectal cancer.

27 May 2016

Diabetes societies endorse 'metabolic surgery'

An "unprecedented" number of societies have endorsed guidelines recommending metabolic surgery for patients with diabetes - and not just for patients with severe obesity.

27 May 2016

Spexin harmone may play role in weight gain among teenagers

A Mayo Clinic-led study found that obese teenagers have lower levels of a hormone potentially tied to weight management than teens of normal weights. The study is published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

27 May 2016

Study reveals males and females exhibit different stress responses

How does stress - which, among other things, causes our bodies to divert resources from non-essential functions - affect the basic exchange of materials that underlies our everyday life? Weizmann Institute of Science researchers investigated this question by looking at a receptor in the brains of mice, and they came up with a surprising answer.

27 May 2016

Normoglycaemia key to improved neurological outcome after paediatric stroke

Achieving normal blood glucose concentrations may be important in preventing poor neurological outcomes in children following acute arterial ischemic stroke, a retrospective review indicates.

27 May 2016

Clinical study supports safety, efficacy of GI Windows’ IAS as treatment option for Type 2 diabetes

GI Windows, Inc., a clinical-stage medical device company, today announced the presentation of six-month results of the first-ever clinical study evaluating the endoscopic creation of a dual-path enteral diversion using the company’s Incision-less Anastomosis System (IAS) at Digestive Disease Week® 2016 (DDW), in San Diego, Calif.

26 May 2016

Majority of young adults with abdominal obesity unaware of CKD risk

Many young adults with abdominal obesity exhibit a readily detectable risk factor for chronic kidney disease (CKD), yet the vast majority don't know they're at risk, according to a study of nationwide health data led by Albert Einstein College of Medicine researchers that was published online today in the journal PLOS ONE.

26 May 2016